APA

Devriese L. A., Witteveen P. E. O., Wanders J., Law K., Edwards G., Reyderman L., Copalu W., Peng F., Marchetti S., Beijnen J. H., Huitema A. D. R., Voest E. E. & Schellens J. H. M. (20130701). Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin. : British journal of clinical pharmacology.

Chicago

Devriese Lot A, Witteveen Petronella Els O, Wanders Jantien, Law Kenneth, Edwards Geoff, Reyderman Larisa, Copalu William, Peng Fuping, Marchetti Serena, Beijnen Jos H, Huitema Alwin D R, Voest Emile E and Schellens Jan H M. 20130701. Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin. : British journal of clinical pharmacology.

Harvard

Devriese L. A., Witteveen P. E. O., Wanders J., Law K., Edwards G., Reyderman L., Copalu W., Peng F., Marchetti S., Beijnen J. H., Huitema A. D. R., Voest E. E. and Schellens J. H. M. (20130701). Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin. : British journal of clinical pharmacology.

MLA

Devriese Lot A, Witteveen Petronella Els O, Wanders Jantien, Law Kenneth, Edwards Geoff, Reyderman Larisa, Copalu William, Peng Fuping, Marchetti Serena, Beijnen Jos H, Huitema Alwin D R, Voest Emile E and Schellens Jan H M. Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin. : British journal of clinical pharmacology. 20130701.